Co-Diagnostics' IPO

Co-Diagnostics raised a round of funding on July 12, 2017. Investors include Public.

Co-Diagnostics (NASDAQ: CODX) is a molecular diagnostics company that has developed and intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analys…

Articles about Co-Diagnostics' IPO: